drugstore.com
drugstore.com is a technology company.
Closed
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at drugstore.com.
drugstore.com is a technology company.
Key people at drugstore.com.
Key people at drugstore.com.
drugstore.com was an early e-commerce pioneer in health, beauty, and pharmacy products, offering over 60,000 items including over-the-counter drugs, vitamins, and beauty supplies with convenient online ordering and partnerships for in-store prescription pickups.[2][3][5] Launched in 1999, it served busy consumers seeking a broader selection than traditional brick-and-mortar stores, achieving rapid growth with 3 million customers and $456 million in 2010 revenue before its $409 million acquisition by Walgreens in 2011, after which operations shut down in 2016.[2][4][5] Despite never turning an annual profit, it innovated with features like the first inventory information approval system (IIAS) and strategic alliances with Rite Aid and GNC.[1][3]
Founded in 1998 and launching web operations on February 24, 1999, drugstore.com emerged during the dot-com boom to deliver pharmacy services and "drugstore stuff" online, addressing space limitations in physical stores.[1][2][3] Backed by high-profile investors like Kleiner Perkins Caufield & Byers, with board members including Jeff Bezos, Howard Schultz, and Melinda Gates, it was once led by Microsoft executive Peter Neupert.[4] Early traction came via a June 1999 partnership with Rite Aid for prescription fulfillment and GNC vitamins, plus aggressive marketing spends like $28.5 million in its first year; it went public in 1999, peaking at $67.50 per share before the dot-com bust eroded value.[1][2][4] A 2005 split from Amazon sourcing and 2009 marketplace deal marked pivots amid challenges.[2][4]
drugstore.com rode the late-1990s e-commerce wave, capitalizing on rising internet adoption for non-perishable goods like health/beauty items while navigating prescription hurdles that brick-and-mortar giants like Walgreens (est. 1901) and CVS (est. 1963) dominated.[1][2] Timing mattered amid dot-com hype—its 1999 IPO and partnerships timed with consumer shift to online convenience, influencing early digital retail models despite regulatory/logistical barriers in pharma (e.g., cold storage, pharmacist needs).[3] It pressured incumbents to accelerate online strategies, as seen in Walgreens' 2011 acquisition to gain 3M customers and 60K SKUs, boosting omni-channel retail; its 2016 shutdown highlighted market consolidation favoring integrated players.[2][4][5]
drugstore.com's arc—from dot-com darling to Walgreens asset—illustrates e-pharma pitfalls like perpetual losses ($115.8M in 1999 alone) and regs, but its legacy endures in modern platforms like Amazon Pharmacy or Walmart+.[1][3] Post-2016 shutdown, no revival exists; influence lives in omni-channel norms it helped pioneer, with trends like AI-driven personalization and drone delivery shaping successors.[3] As an early tech play in retail, it underscores how timing and execution turn convenience into scale—or acquisition exits—tying back to its roots as a bold bet on digital drugstore access.
